Middle East And Africa Male Infertility Market 2023-2030

Middle East And Africa Male Infertility Market 2023-2030

MARKET OUTLOOK

Triton Market Research’s report insinuates that the male infertility market in the Middle East and Africa is anticipated to advance in value at a compound annual growth rate of 5.02% during the forecast years 2023-2030. South Africa, Turkey, Saudi Arabia, the UAE, and Rest of Middle East & Africa are taken into consideration in the region.

In the UAE, a decline in fertility rates, expansion of fertility centers and clinics, and supportive government policies are among the major factors expected to contribute to the growth of male infertility. For instance, the fertility rate has declined by 0.94% since 2021. Further, the country witnessed an expansion of fertility centers and clinics specializing in different treatments. Therefore, as stated above, these factors support the expansion of the male infertility market.

Furthermore, in Turkey, the market is expected to witness substantial growth on account of the rising prevalence of diseases reducing fertility rates and medical tourism. According to industry sources, the number of people diagnosed with diabetes is expected to rise to 10.8 billion by 2030. Such a substantial increase in diabetes prevalence is likely to have a negative impact on male fertility rates, thereby elevating the demand for infertility treatments.

COMPETITIVE OUTLOOK

The notable companies in the male infertility market consist of Vitrolife, Halotech DNA, Endo International Plc, EMD Serono Inc, and Bayer AG.